Showing results (371-380 of 1,523) with videos related to
Sort By:
Pageof 153
CPT: Pharmacometrics & Systems Pharmacology|May 6, 2022
Predicting disease activity in patients with multiple sclerosis: An explainable machine-learning approach in the Mavenclad trialsSreetama Basu, Alain Munafo, Ali-Frederic Ben-Amor, et al.CPT: Pharmacometrics & Systems Pharmacology|January 16, 2023
Cell state-directed therapy - epigenetic modulation of gene transcription demonstrated with a quantitative systems pharmacology model of temozolomideAnshul Saini, Annabelle Ballesta, James M GalloCPT: Pharmacometrics & Systems Pharmacology|December 20, 2022
Interspecies and in vitro-in vivo scaling for quantitative modeling of whole-body drug pharmacokinetics in patients: Application to the anticancer drug oxaliplatinSimona Catozzi, Roger Hill, Xiao-Mei Li, et al.CPT: Pharmacometrics & Systems Pharmacology|December 20, 2022
Variable or variate? A conundrum in pharmacometrics exposure-response modelsAna-Marija Grisic, Karthik Venkatakrishnan, Jonathan French, et al.CPT: Pharmacometrics & Systems Pharmacology|December 21, 2022
Verifying in vitro-determined enzyme contributions to cannabidiol clearance for exposure predictions in human through physiologically-based pharmacokinetic modelingCindy H T Yeung, Jessica L Beers, Klarissa D Jackson, et al.CPT: Pharmacometrics & Systems Pharmacology|December 22, 2022
Virtual clinical trials: A tool for predicting patients who may benefit from treatment beyond progression with pembrolizumab in non-small cell lung cancerTimothy Qi, Yanguang CaoCPT: Pharmacometrics & Systems Pharmacology|June 7, 2022
Evaluation of covariate effects using forest plots and introduction to the coveffectsplot R packageJean-Francois Marier, Nathan Teuscher, Mohamad-Samer MouksassiCPT: Pharmacometrics & Systems Pharmacology|June 24, 2022
Altered intravenous drug disposition in people living with cystic fibrosis: A meta-analysis integrating top-down and bottom-up dataPieter-Jan De Sutter, Maxime Van Haeverbeke, Eva Van Braeckel, et al.CPT: Pharmacometrics & Systems Pharmacology|June 27, 2022
Longitudinal and time-to-event modeling for prognostic implications of radical surgery in retroperitoneal sarcomaYe Yao, Zhen Wang, Ling Yong, et al.CPT: Pharmacometrics & Systems Pharmacology|May 4, 2022
Evaluation of drug-drug interaction potential for pemigatinib using physiologically based pharmacokinetic modelingTao Ji, Xuejun Chen, Swamy YeleswaramPageof 153